VORONOI, a leading biotech in South Korea EGFR-Exon20Ins Lisenced out to ORIC Parmaceuticals in 2020 RET-Fusion Lisenced out to Inno.N in 2021 Anticipated upcoming IPO on KOSDAQ for 4Q, 2021
KOSDAQ surged 6.06% to 1116.18 on April 1, driven by foreign and institutional buying. Battery, biotech, semiconductor, and optical communication stocks rallied significantly.
Voronoi decides to dispose of 203,401 treasury shares
Voronoi to dispose of 203,401 treasury shares on December 30, 2025 through off-market transaction to secure operating funds and improve financial stability.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.